G
GL Pharm Tech Corp
KOSDAQ:204840
GL Pharm Tech Corp
KOSDAQ:204840
Price:
1 096
KRW
0.37%
Market Closed
Market Cap:
₩85B
Balance Sheet
Balance Sheet Decomposition
GL Pharm Tech Corp
GL Pharm Tech Corp
Balance Sheet Decomposition is not available for
GL Pharm Tech Corp
GL Pharm Tech Corp
Balance Sheet
GL Pharm Tech Corp
GL Pharm Tech Corp
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
309
|
256
|
584
|
362
|
1 732
|
324
|
9 490
|
6 189
|
4 639
|
4 136
|
4 258
|
|
| Cash |
0
|
0
|
0
|
362
|
1 732
|
324
|
9 490
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
309
|
256
|
584
|
0
|
0
|
0
|
0
|
6 189
|
4 639
|
4 136
|
4 258
|
|
| Short-Term Investments |
9 500
|
9 500
|
6 662
|
7 824
|
1 200
|
334
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
27
|
154
|
1 521
|
1 514
|
3 943
|
3 560
|
3 643
|
3 690
|
5 708
|
5 811
|
6 056
|
|
| Accounts Receivables |
27
|
151
|
1 473
|
1 471
|
3 726
|
3 360
|
3 522
|
3 480
|
5 523
|
5 618
|
5 809
|
|
| Other Receivables |
0
|
3
|
48
|
43
|
217
|
200
|
121
|
210
|
185
|
192
|
247
|
|
| Inventory |
0
|
0
|
60
|
0
|
1 626
|
2 100
|
2 742
|
3 387
|
5 508
|
6 640
|
8 550
|
|
| Other Current Assets |
0
|
0
|
177
|
0
|
478
|
29
|
95
|
3
|
334
|
33
|
150
|
|
| Total Current Assets |
9 836
|
9 911
|
9 005
|
9 701
|
8 979
|
6 348
|
15 970
|
13 270
|
16 190
|
16 619
|
19 014
|
|
| PP&E Net |
0
|
0
|
1 447
|
2 117
|
15 847
|
15 733
|
15 636
|
15 465
|
19 850
|
18 864
|
18 127
|
|
| PP&E Gross |
0
|
0
|
0
|
2 117
|
15 847
|
15 733
|
15 636
|
15 465
|
19 850
|
18 864
|
18 127
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
2 594
|
5 733
|
6 972
|
8 112
|
9 559
|
10 167
|
11 777
|
12 979
|
|
| Intangible Assets |
0
|
0
|
120
|
139
|
2 849
|
2 849
|
2 348
|
1 916
|
1 479
|
1 028
|
1 680
|
|
| Goodwill |
0
|
0
|
0
|
0
|
2 416
|
278
|
278
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
120
|
256
|
201
|
87
|
99
|
170
|
176
|
34
|
|
| Long-Term Investments |
0
|
0
|
1 698
|
2 711
|
901
|
736
|
526
|
1 024
|
3 020
|
2 988
|
3 008
|
|
| Other Long-Term Assets |
0
|
0
|
82
|
234
|
313
|
402
|
101
|
121
|
145
|
194
|
577
|
|
| Other Assets |
0
|
0
|
0
|
0
|
2 416
|
278
|
278
|
0
|
0
|
0
|
0
|
|
| Total Assets |
9 836
N/A
|
9 911
+1%
|
12 351
+25%
|
15 021
+22%
|
31 562
+110%
|
26 547
-16%
|
34 945
+32%
|
31 895
-9%
|
40 854
+28%
|
39 868
-2%
|
42 440
+6%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
861
|
1 030
|
895
|
623
|
3 104
|
2 564
|
1 970
|
|
| Accrued Liabilities |
0
|
0
|
0
|
97
|
274
|
361
|
621
|
686
|
1 624
|
1 045
|
574
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1 835
|
1 812
|
1 513
|
1 500
|
1 550
|
3 900
|
2 983
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1 860
|
3 633
|
1 052
|
10 148
|
2 737
|
819
|
4 902
|
2 558
|
5 790
|
|
| Other Current Liabilities |
2
|
4
|
954
|
725
|
1 582
|
2 809
|
1 896
|
1 237
|
1 923
|
2 252
|
2 596
|
|
| Total Current Liabilities |
2
|
4
|
2 814
|
4 455
|
5 603
|
16 159
|
7 662
|
4 865
|
13 104
|
12 319
|
13 914
|
|
| Long-Term Debt |
1 364
|
1 415
|
132
|
3 501
|
12 372
|
3 735
|
8 767
|
5 560
|
7 458
|
11 327
|
5 877
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
2 369
|
2 327
|
2 818
|
2 243
|
2 200
|
2 005
|
2 010
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
630
|
0
|
0
|
0
|
|
| Other Liabilities |
32
|
37
|
837
|
1 130
|
3 401
|
1 963
|
1 384
|
1 748
|
2 002
|
1 935
|
971
|
|
| Total Liabilities |
1 398
N/A
|
1 456
+4%
|
3 783
+160%
|
9 086
+140%
|
23 745
+161%
|
24 185
+2%
|
20 630
-15%
|
15 046
-27%
|
24 764
+65%
|
27 586
+11%
|
22 772
-17%
|
|
| Equity | ||||||||||||
| Common Stock |
450
|
450
|
3 022
|
3 172
|
3 578
|
3 578
|
5 223
|
6 185
|
6 210
|
6 235
|
7 697
|
|
| Retained Earnings |
7
|
10
|
6 755
|
10 933
|
16 299
|
7 992
|
11 193
|
15 313
|
15 853
|
19 736
|
22 111
|
|
| Additional Paid In Capital |
7 995
|
7 995
|
12 186
|
13 697
|
20 538
|
6 776
|
20 285
|
25 795
|
25 558
|
25 615
|
34 067
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
115
|
0
|
0
|
0
|
0
|
182
|
175
|
168
|
15
|
|
| Total Equity |
8 438
N/A
|
8 455
+0%
|
8 568
+1%
|
5 935
-31%
|
7 817
+32%
|
2 362
-70%
|
14 315
+506%
|
16 849
+18%
|
16 090
-5%
|
12 282
-24%
|
19 668
+60%
|
|
| Total Liabilities & Equity |
9 836
N/A
|
9 911
+1%
|
12 351
+25%
|
15 021
+22%
|
31 562
+110%
|
26 547
-16%
|
34 945
+32%
|
31 895
-9%
|
40 854
+28%
|
39 868
-2%
|
42 440
+6%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
5
|
5
|
32
|
34
|
38
|
36
|
47
|
62
|
62
|
62
|
77
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
